Page 3 - சரிபார்த்தல் ஔட்‌கம் இயக்குனர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சரிபார்த்தல் ஔட்‌கம் இயக்குனர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சரிபார்த்தல் ஔட்‌கம் இயக்குனர் Today - Breaking & Trending Today

High Performing Pumps Maintain Vaccine Quality

Mar 10 2021 Read 165 Times
Vaccine discovery and production has jumped to top of the priority list for most pharmaceutical companies. Increased interest in developing biopharmaceutical therapeutics with injection-delivered large-molecules has shone the light on aseptic processing in both upstream and downstream operations. Stricter validation requirements and a need for design innovation have led manufacturers to demand more from their peristaltic pump suppliers.
The Longer Pump series from PCT offer many clear benefits for both production and quality control engineers. The utilisation of single use tubing within peristaltic pumps eliminates the risk of cross-contamination and, as only the inside of the tubing comes into contact with the media, it also eliminates lengthy cleaning procedures. Validation is therefore significantly easier. As many biological drugs are shear-sensitive, the gentle action of peristaltic pumps protects them by applying only low pressure ....

Longer Pump , நீண்டது பம்ப் ,

Akoya and Johns Hopkins' collaboration

Akoya and Johns Hopkins’ collaborative agreement supports pioneering new approach to immunotherapy biomarker discovery and validation
Industry News: Akoya and Johns Hopkins’ collaborative agreement supports pioneering new approach to immunotherapy biomarker discovery and validation
For the first time Astronomy and Pathology (AstroPath™) come together to discover and clinically validate new spatial phenotypic signatures using multiplex immunofluorescence
03 Mar 2021
®, has announced a collaboration with the Bloomberg-Kimmel Institute for Cancer Immunotherapy (BKI) and the Bloomberg Center for Physics and Astronomy at the Johns Hopkins University School of Medicine.
The agreement brings together Akoya’s Phenoptics™ multiplex immunofluorescence (mIF) platform for spatial phenotyping and Johns Hopkins’ AstroPath™ platform, an interdisciplinary team of immunologists, pathologists, oncologists, and astrophysicists focused on immuno-oncology biomarker ....

Janis Taube , Brian Mckelligon , Cliff Hoyt , Alex Szalay , Akoya Phenoptics , Johns Hopkins , Johns Hopkin Astropath , Johns Hopkin , Bloomberg Kimmel Institute For Cancer Immunotherapy , Division Of Dermatopathology , Johns Hopkins University School Of Medicine , Department Of Computer Science , Akoya Biosciences Inc , Spatial Biology Company , Bloomberg Center , Scientific Affairs At Akoya , Industry News , Spatial Biology , Bloomberg Kimmel Institute , Johns Hopkins University School , Drew Pardoll , Kimmel Institute , Bloomberg Distinguished Professor , Computer Science , Vice President , Scientific Affairs ,

North Korean defectors sue unification minister for defamation

North Korean defectors sue unification minister for defamation
Posted : 2021-02-22 17:04
Updated : 2021-02-23 10:29
Choi Seong-kuk, third from left, a North Korean defector who is a cartoonist and human rights activist here, speaks during a press conference in front of the Seoul Central District Court, Monday, before filing a defamation lawsuit against Unification Minister Lee In-young together with three other defectors. Screenshot from Mulmangcho s YouTube account
By Jung Da-min
Four North Korean defectors are suing Unification Minister Lee In-young for defamation over his recent remarks which they claim treated defectors as liars.
The four, with help from Mulmangcho, an organization that supports North Korean defectors adjust to life in the South, held a press conference in front of the Seoul Central District Court, Monday, to condemn the minister who said testimony from North Korean defectors needed verification and validation. They said Lee s rem ....

Soult Ukpyolsi , South Korea , North Korea , North Korean , South Korean , Republic Of Korea , North Koreans , Mulmangcho Youtube , Chung Eui Yong , Choi Seong Kuk , Lee Jong Joo , Seoul Central District Court , Unification Committee , National Assembly Foreign Affairs , Unification Minister Lee In Young , Kim Jong Il , Kim Jong Un , Minister Lee In Young , Foreign Minister Chung , Kim Tae Hee , Unification Minister , Lee In Young , Press Conference , Human Rights , International Community , தெற்கு கொரியா ,

Greater Pharmaceutical Adoption of Raman Spectroscopy with New USP Chapters

Feb 17 2021 Read 14139 Times
The NanoRam family of handheld Raman instruments from B&W Tek is used globally for incoming raw material identification in the pharmaceutical industry. With the growing use of handheld Raman, the pharmacopeial chapters for Raman spectroscopy have followed and added more information and guidance for system testing. The replacement of USP 1120 Raman Spectroscopy with two new chapters, USP 858 Raman Spectroscopy and USP 1858 Raman Spectroscopy – Theory and Practice went into effect, reflects the regulatory recognition of Raman spectroscopy as a valuable technology to the industry.
NanoRam and NanoRam-1064 systems are calibrated in compliance with the wavelength accuracy criteria for qualitative Raman measurements set forth by all global pharmacopeias, including the new USP 858 and 1858 chapters. The system software of the NanoRam and NanoRam-1064 includes performance validation testing using Raman shift standard materials as defined b ....

Raman Shift Standards , ராமன் மாற்றம் தரநிலைகள் ,

Polpharma Biologics Announces Rebrand and Launch of New Value We Care as 2000 L Bioreactors Begin Validation at Its Warsaw Site

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005383/en/
Dr Joerg Windisch, CEO of Polpharma Biologics, said Our new brand represents our passion and dedication to innovation, we utilize the latest technology and cutting-edge techniques to discover and advance ground breaking biologics to the clinic, whether this is our own pipeline or that of our partners.
The industry is rapidly reducing the time to develop and manufacture new molecules, this is down to significant improvements in automation with many previously time consuming steps replaced with equipment that can analyze thousands of samples in minutes incredibly accurately. Throughout our entire process from early stage discovery, through cell line development and process development and to fill finish we have adopted the very latest technology to ensure we can offer the best timelines and most comprehensive analytics to generate the highest qualit ....

Polpharma Biologics , Kostenloser Wertpapierhandel , Joerg Windisch , Frank Ternes , Global Head , வெளிப்படையான டேர்னேஸ் , உலகளாவிய தலை ,